|
Volumn 28, Issue 3, 1996, Pages 1324-1326
|
Cyclosporine pharmacokinetics profiles in stable renal allograft recipients converting from Sandimmun to Neoral
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATININE;
CYCLOSPORIN;
CYCLOSPORIN A;
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG FORMULATION;
FEMALE;
FLUORESCENCE POLARIZATION IMMUNOASSAY;
GRAFT REJECTION;
HUMAN;
HYPERTENSION;
KIDNEY ALLOGRAFT;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
MALE;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ALLOTRANSPLANTATION;
ARTICLE;
BLOOD;
CHRONIC KIDNEY FAILURE;
COMPARATIVE STUDY;
CROSSOVER PROCEDURE;
DRUG DOSAGE FORM;
IMMUNOLOGY;
KIDNEY FUNCTION TEST;
LIVER FUNCTION TEST;
PHYSIOLOGY;
TIME;
ADMINISTRATION, ORAL;
ADULT;
ALANINE TRANSAMINASE;
ASPARTATE AMINOTRANSFERASES;
CREATININE;
CROSS-OVER STUDIES;
CYCLOSPORINE;
DOSAGE FORMS;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY FUNCTION TESTS;
KIDNEY TRANSPLANTATION;
LIVER FUNCTION TESTS;
MALE;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0029665768
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (6)
|
References (0)
|